LOUISA ASARE: Open Payments
NPI 1598278756 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 37 payments from 20 companies in 2025. Trend: 2023 $132 · 2024 $1,554 · 2025 $1,090
Food & beverage: $895Education: $195
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $204 |
| Incyte Corporation | 2 | $112 |
| AstraZeneca Pharmaceuticals LP | 3 | $83 |
| TerSera Therapeutics LLC | 3 | $80 |
| JAZZ PHARMACEUTICALS INC. | 2 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $67 |
| Geron Corporation | 2 | $56 |
| Celgene Corporation | 2 | $53 |
| Janssen Pharmaceuticals, Inc | 2 | $46 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $44 |
Products named: ERLEADA, RYTELO, Xermelo, TECVAYLI, RYBREVANT, OPDIVO, ZEPZELCA, ZIIHERA.
Industry payments across TX — which companies pay providers there.
